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Abstract.  Dynamic reorganization  of the actin 
microfilament networks is dependent on the reversible 
phosphorylation of myosin light chain.  To assess the 
potential role of protein phosphatases in this process 
in living nonmuscle cells, we have microinjected the 
purified type-1 and type-2A phosphatases into the 
cytoplasm of mammalian fibroblasts. Our studies re- 
veal that elevating type-1 phosphatase levels led to the 
rapid (within 30 rain) and fully reversible disassembly 
of the actin microfilament network as determined by 
immunofluorescence analysis. In contrast,  microinjec- 
tion of equivalent amounts of the purified type-2A 
phosphatase had no effect on actin microfilament orga- 
nization.  Metabolic labeling of cells after injection of 
purified phosphatases was used to analyze changes in 
protein phosphorylation.  Concomitant with the disas- 
sembly of the actin microfilaments induced by type-1 
phosphatase,  there was an extensive dephosphorylation 
of myosin light chain.  No such change was observed 
when cells were injected with type-2A phosphatase.  In 
addition,  after extraction of fibroblasts with Triton 
X-100, the type-1 phosphatase could be specifically 
localized by immunofluorescence to a fibrillar network 
of microfilaments.  Furthermore,  neutralizing  type-1 
phosphatase activity in vivo by microinjection of an 
afffinity-purified  antibody, prevented the reorganization 
of actin microfilaments that we had previously de- 
scribed following injection of cAMP-dependent protein 
kinase.  These data support the notion that type 1 and 
type-2 phosphatases have distinct substrate specificity 
in living cells, and that type-1 phosphatase plays a 
predominant role in the dephosphorylation of myosin 
light chain and thus in the modulation of actin micro- 
filament organization  in vivo in intact nonmuscle cells. 
EVERSIBLE protein  phosphorylation  is  well  known 
to play an implicit  role in the mechanisms that reg- 
ulate actomyosin contractility  (1, 18-20, 27; reviewed 
in references  32, 43). There has been a consensus that the 
increased  phosphorylation  of the  20-22-kD  myosin  light 
chain component of the myosin complex coincides with the 
increased contractility  of smooth and skeletal muscle tissue 
(2, 5, 19, 20, 41; reviewed in references 2, 27, 32, 43), and 
is related to changes in actin organization  and cell shape in 
nonmuscle cells (6, 33).  A calcium/calmodulin-dependent 
enzyme, myosin light chain kinase (MLCK), 1  catalyzes this 
reaction (3,  17; reviewed in references  32, 43). More con- 
troversial  has  been understanding  the mechanisms  which 
bring about the regulation  of this enzyme in living muscle 
cells,  since in addition  to its activation  by calmodulin  (17; 
reviewed in reference 32), MLCK activity can be modulated 
through direct phosphorylation by the cAMP-dependent pro- 
1. Abbreviations used in this paper: A-kinase, cAMP-dependent  protein ki- 
nase; MLC,  myosin light chain; MLCK,  myosin light chain kinase;  PP-I, 
type-l protein phosphatase; PP-2A, type-2A protein phosphatase; REF-52, 
rat embryo fibroblast. 
tein kinase (A-kinase) (3, 17, 28; reviewed in references 32, 
43).  We have recently shown that  inhibition  of MLCK by 
microinjection of anti-MLCK antibodies into the mammalian 
cell line REF-52 led to the dephosphorylation of myosin light 
chain,  and the disassembly of the actin microfilament  net- 
work (33).  Moreover,  a  similar  effect was obtained when 
cells were injected with the catalytic subunit  for A-kinase 
and coincided with the increased phosphorylation of MLCK 
(33).  Since these events were accompanied by the dephos- 
phorylation of the myosin light chains,  we therefore postu- 
lated that myosin light chain dephosphorylation was an inte- 
gral process in actomyosin relaxation  in nonmuscle cells. 
Similar effects of A-kinase had been observed previously in 
studies of smooth muscle tissue (17, 20, 28; reviewed in refer- 
ence 43),  where treatment  of skinned  muscle fibers  with 
agents that activate A-kinase led to muscle relaxation.  These 
studies (and others; reviewed in reference 32) were restricted, 
however, by the difficulty in observing or identifying the con- 
comitant dephosphorylation of myosin light chains  and re- 
laxation of actomyosin in the tetanized  smooth muscle fibers 
(20).  Whereas  there is some recent evidence that cAMP- 
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myosin dephosphorylation (19), there stir remain clear cases 
(also cited in reference 19) where either mechanisms  inde- 
pendent of cAMP bring about the relaxation of smooth mus- 
cle or the maintenance of contractile force occurs after the 
dephosphorylation of myosin (~viewed in reference 32). How- 
ever, addition of purified phosphatase to skinned fibers did 
cause decrease in tension suggesting that myosin light chain 
(MLC) dephosphorylation is involved in muscle relaxation 
(9,  10, 26, 29). 
Whereas the mechanisms that control myosin phosphory- 
lation by MLCK are now better understood,  less is known 
of the enzymes that bring about MLC dephosphorylation in 
vivo. Indeed, in comparison to our understanding of protein 
kinases,  knowledge  of the regulation,  structure, and sub- 
strate specificity of protein phosphatases is underdeveloped. 
The two predominant and best studied serine and threonlne 
protein phosphatases, type-1 and type-2A (PP-1 and PP-2A, 
respectively)  (reviewed in references 4,  16),  show distinct 
functional properties, in particular their sensitivity to specific 
inhibitor proteins (reviewed in references 4,  16). However, 
as reviewed by Cohen (16), PP-1 and PP-2A show broad and 
overlapping specificities  in vitro (although there is evidence 
that these phosphatases  catalyze  the dephosphorylation  of 
certain substrates at different rates [4, 13, 16] and their pre- 
cise functions  in vivo are as yet unknown.  Since both en- 
zymes have been previously proposed to be involved in the 
dephosphorylation of the myosin light chain (9,  10, 14,  15, 
22, 26, 35, 39, 45; reviewed in references 16, 43), we chose 
to examine the consequences of elevating intraceUular phos- 
phatase levels through microinjection of the purified type-1 
and type-2A phosphatases in rat embryo fibroblasts. These 
studies reveal that only type-1 pbosphatase induced rapid and 
reversible  changes  in  microfilament  organization,  which 
mimic  those  observed  after  inhibition  of MLCK  activity 
(33). Furthermore, microinjection of type-1 phosphatase in- 
duced the dephosphorylation of the myosin light chain where- 
as type-2A did not. These studies demonstrate a high degree 
of substrate specificity  between the two enzymes in living 
fibroblasts, not necessarily anticipated from previous in vitro 
analysis, and an important role for type-1 phosphatase in the 
regulation of actomyosin. 
Materials and Methods 
Microinjection and Cell Culture 
Rat embryo fibroblast (REF-52),  were cultured in DME supplemented with 
8.0% FCS in a humidified atmosphere containing 5.0% CO2. Cells were 
grown and suboultured  onto glass coverslips  for immunofluorescence  and 
microinjection as described elsewhere (33).  For microinjection studies, 
ceils were microinjected with purified phosphatase enzymes (or antibodies) 
diluted immediately before microinjection into an injection buffer (100 mM 
K  + glutamate, 39 mM K + citrate, pH 7.3) containing 0.5 mg/ml inert im- 
munoglobulins (to act subsequently as an inert marker in identifying micro- 
injected cells) (34). 
Phosphatases and Kinase Purification and Use 
The homogeneous 33-kD catalytic fragraent of type-1 protein phosphatase 
(PP-1) was purified from rabbit skeletal muscle as described elsewhere (11). 
In most experiments, PP-1, one of four preparations, was diluted to a final 
concentration of 0.5 mg/ml (with asp act ,,o11,000-17,000 U/rag [25]; we 
also assayed a range of concentrations from 0.1--0.75 mg/ml). The catalytic 
subunit type-2A protein phosphatase (one of tw~ preparations) was purified 
to homogeneity from bovine cardiac muscle by ethanol precipitation as de- 
scribed before (35). Both the native (complexed to regulatory subunit) and 
catalytic preparations of PP-2A were microinjected in the concentration 
range 0.1-1.6 mg/ml. The phosphatase was diluted from a 1.3-1.8 mg/ml so- 
lution (sp act ,~,8,000-10,000 U/rag) to the same specific catalytic activity 
as type4 preparations. We have used maximum catalytic activity of each 
pbosphatase directed against their best in vitro substrate, i.e., phosphory- 
lase-a for PP-I  (11) and isolated MLC for PP-2A (35) in equilibrating the 
amounts of each phosphatase injected. Indeed, since PP-I is two- to three- 
fold less active than PP-2A towards isolated MLC, normalizing the activi- 
ties of the two enzymes toward this substrate would have resulted in our un- 
derestimating the appropriate activity for PP-2A.  To compensate for the 
apparent differences in in vitro reactivity of PP-1 and PP-2A for myosin light 
chain (isolated or complaxed)  we have injected a four- to fivefold range of 
activities for either enzyme.  The catalytic subunit of cAMP-dependent  pro- 
tein kinase (A-kinase) was purified from beef heart as described (7). Cells 
were injected with a 0.5 mg/ml solution of A-kinase diluted in injection 
buffer. Proteins were stored at -20°C before use. Activities of all proteins 
were confirmed before microinjection. 
lmmunofluorescence 
Microinjected cells growing on glass coverslips were fixed at various times 
after injection in 3.7% formalin in PBS for 5 min. After brief extraction in 
-20°C  acetone,  actin microfilaments  were visualized  with rhodamine- 
conjugated phalloidin (rh-phalloidin), a specific stain for F-actin (a gener- 
ous girl from Prof. T. Weiland, Max Planck Institute,  Heidelberg,  Federal 
Republic  of Germany). Cells were simultaneously stained for the co-in- 
jected inert marker antibody with affinity-purified  fluorescein  conjugated 
anti-rabbit antibodies and mounted in Airvol-205 before examination and 
photography on an Axiopbot photomicroscope as described elsewhere (34). 
To examine the distribution of phosphatase type-I in REF-52 cells,  cells 
were extracted  in  100 mM K+-Hepe s  (pH  7.2),  1 mM  MgSO4,  0.3% 
(vol/vol) Triton X-100 for 30 s. Immediately afterward cells were fixed in 
formalin and extracted with acetone as described above and subsequently 
stained for the distribution of phosphatase type-1 and affinity-purified sheep 
antibodies raised against the catalytic subunit of type-I phosphatase purified 
from rabbit skeletal muscle (11). Primary antibody distribution  was revealed 
using fluorescein-conjugated  rabbit anti-sheep Igs (Cappel, Organon Tech- 
nika, Fresnes Cedex, France). Cells were concomitantly stained for the dis- 
tribution of actin using rh-phalloidin as described above. 
For studies in which cells were injected with antibodies directed against 
type-1 phosphatase (injected over a range of concentrations from 0.1 to 1.0 
mg/ml), the same affinity-purified sheep antibody as used above was diluted 
into injection buffer containing type-2A phosphatase or the cAMP-depen- 
dent protein kinase. Injection solutions also contained an inert marker anti- 
body. Cells were fixed and stained for the distribution of actin as described 
above. 
Metabolic Labeling 
Ceils growing on small glass coverslips were microinjected and metaboli- 
cally pulse labeled as described previously (33). Phosphatase proteins were 
microinjected in the same buffer as described above with the exception that 
the marker antibody was omitted. After labeling phosphoprotein patterns 
were  analyzed by two-dimensional  PAGE before autoradiography as de- 
scribed before (33). 
Results 
Microfilament Reorganization Occurs after 
Microinjection of ~ype-1 Phosphatase, 
Not Type-2A Phosphatase 
We have previously shown that the distribution of actin mi- 
crofilaments in mammalian fibroblasts can be markedly al- 
tered through activation of the cAMP-dependent A-kinase or 
through inactivation of the MLCK,  and this reorganization 
was also accompanied by the pronounced dephosphorylation 
of MLC (33).  To identify  the phosphatase responsible  for 
this MLC dephosphorylation,  we used the same cells as in 
our previous  study, rat embryo  fibroblasts REF-52  cells. 
The Journal of Cell Biology, Volume 111, 1990  104 Figure 1. Microinjection of protein phosphatase typed induces actin microfilament disassembly. Rat embryo fibroblasts (REF-52) growing 
on glass coverslips were microinjected with either mieroinjection buffer or the purified catalytic fragment of PP-1 (0.5 mg/ml, '~15,000 
U/mg, 7,500 U/ml). At different times thereafter the cells were fixed and stained for the distribution of actin microfilaments as described 
in Materials and Methods. All solutions for microinjection contained an inert antibody to act as marker in identifying injected cells. Shown 
are fluorescence micrographs of  the distribution of the coinjected marker antibody (,4, (7, and E), or the distribution of actin mierofilaments 
in the same ceils (B, D, and F). (A and B) Cells microinjected with microinjection buffer alone; (C and D) ceils microinjected with PP-1 
and fixed 15 rain thereafter;  and (E and F) cells microinjected with PP-1 and fixed 30 min afterwards. Bar,  10 #m. 
Cells were synchronized into the G~ phase of the cell cycle 
by serum starvation and refeeding (34) since we have ob- 
served that the amount, activity, and distribution of  a specific 
inhibitor for type-1 phosphatase, inhibitor-2, fluctuates in a 
cell cycle-dependent manner. Purified PP-1 was obtained by 
the method of Brautigan et al. (11) from rabbit skeletal mus- 
cle.  For microinjection studies,  purified phosphatase was 
dialyzed into an injection buffer containing 100 mM K÷-glu  - 
tamate, 40 mM K+-citrate,  1.0 mM MgSO4,  pH 7.25 sup- 
plemented with 0.3 mg/ml rabbit anti-mouse Igs to act as an 
inert marker in identifying injected cells. 
Microinjection of the buffer alone (Fig.- 1, A and B) has 
little or no effect on the distribution of actin microfilaments 
as shown in B, with microinj~ted cells containing a similar 
complex distribution of thick and thin filament bundles. In 
contrast, within 15 rain of  injecting PP-1 (0.5 mg/ml, ,'~8,000 
U/ml), the actin microfilaments in injected cells (marked by 
antibody in Fig. 1 C) have begun to reorganize into thicker 
Fernandez et al. Phosphatase Type-1 and Actomyosin Regulation  105 Figure 2. Microinjection  of  type-2A phosphatase does not modulate microfilament  organization. Rat embryo fibroblasts  were microinjected 
with solutions of PP-2A before fixation and staining for the organization of microfilaments  as described in Materials and Methods. Cells 
were microinjected  with either PP-2A alone (at 1.7 mg/ml, '~,10,000 U/mg, 17,000 U/ml) or together with an anti-PP-1 antibody (0.5 mg/nil) 
which inhibits type-1 phosphatase activity. All microinjection solutions also contained an inert marker antibody. Shown are fluorescence 
micrographs of ceUs stained for the distribution of actin (A and C) and for the microinjected marker antibody (B and D). A and B show 
cells microinjected with purified PP-2A  •alone. C and D show cells microinjected with PP-2A and anti-PP-1 antibodies. Bar, 10/xm. 
fibers resulting in an apparent decrease in the overall density 
of the actin staining in comparison to surrounding cells (D). 
By 30 min after injection, injected cells (Fig. 1 E) have con- 
tinued to reorganize their actin and now contain little or no 
detectable actin filament staining (Fig. 1 F). A similar reor- 
ganization of actin can also be observed when injected cells 
are stained with four different anti-actin antibodies or ana- 
lyzed by whole-mount electron microscopy (data not shown), 
indicating that the loss of actin staining does not reflect an 
immunological artifact. Incubating cells for longer periods 
reveals that the filaments have partly reformed by 60 rain af- 
ter microinjection, and little or no difference in actin distri- 
bution can be discerned when comparing PP-1 injected or 
uninjected cells 90 rain after injection (data not shown). We 
observed similar effects on actin microfilament organization 
over quite a wide range of concentrations from 0.3 (5,000 
U/ml) to 0.75 (12,000  U/ml) mg/ml PP-1 in the needle (re- 
flecting 0.03-0.07  mg/ml injected intracellular concentra- 
tion). Below 0.3 mg/ml the effects on filament organization 
were less pronounced, and below 0.1 mg/ml no change in or- 
ganization could be observed (data not shown). 
The effects of PP-1 on actin organization could be abol- 
ished in a number of different ways. Preincubation of puri- 
fied phosphatase with affinity-purified anti-PP-1 antibodies 
(which neutralizes PP-1 activity in vitro)  and  subsequent 
removal of the antibody-phosphatase complex with protein 
A-Sepharose, completely abolishe  d the reorganization ofac- 
tin (data not shown), strongly suggesting that the presence 
of active PP-1 in the injection solution accounted for the 
changes  seen.  This  was  also  confirmed by  injecting the 
anti-PP-l-phosphatase  complex into  the cells  which  also 
resulted in no change in actin organization (data not shown). 
Furthermore, the effect on filament organization could be 
abolished by boiling the preparation for 2 min before injec- 
tion (data not shown). These data (and those showing that 
microinjection of the buffer alone have no effects on actin) 
strongly link the changes in actin staining to the presence of 
active PP-1. We have also observed similar changes in actin 
organization after PP-1 injection in a number of other cell 
lines including Swiss  3T3, rat-2, bovine aortic fibroblasts, 
and human diploid fibroblasts (data not shown). Since type-1 
and type-2A phosphatases exhibit overlapping substrate re- 
activity in vitro, we next examined if elevating intraceUular 
type-2A phosphatase would also induce actin filament reor- 
ganization. In experiments similar to those described above, 
REF-52 cells were injected with a solution of purified cata- 
lytic subunit of type-2A phosphatase (PP-2A), purified from 
bovine cardiac muscle (35). To ensure that studies were com- 
parable, the same units of maximum catalytic activity of ei- 
ther phosphatases were used for microinjection studies. (PP-1 
The Journal of Cell Biology, Volume 111,  1990  106 Figure 3. Dephosphorylation of myosin light chain accompanies activation of type-1 phosphatase but not type-2A. Rat embryo fibroblasts 
growing on 2 mm  2 glass coverslips were microinjected with either microinjection buffer, purified phosphatase type-I (0.5 mg/ml), or 
purified phosphatase type-2A (1.7 mg/ml). Immediately afterwards cells were incubated in 5/~1 of l~2p]orthophosphate in DME for 30 
rain. At the end of the labeling period,  cells were lysed in boiling sample buffer and analyzed by two-dimensional PAGE as described 
in Materials and Methods. Shown are autoradiograms of the region of the gels that include myosin light chain. A shows myosin light chain 
phosphorylation in cells injected with microinjection buffer, B shows the same region of  the gel from cells injected with phosphatase type-l, 
C shows a similar region from cells injected with type-2A pbosphatase. D shows a similar region of a gel after injection of PP-2A and 
after transfer to nitrocellulose. The nitrocellulose was subsequently reacted with rabbit anti-myosin light chain and developed for anti- 
rabbit. Shown are the positions where the myosin light chain reacted with this antibody. Marked on the autoradiographs and the blot is 
the position of the myosin light chain (arrows), and the direction of the first- and second-dimension electrophoresis. The acidic side of 
the gel is to the fight. 
was assayed with phosphorylase-a as substrate [11], PP-2A 
with isolated MLC as substrate [35]). Since the isolated my- 
osin light chain differs in its capacity to act as substrates for 
PP-1 and PP-2A (being an approximately two- to threefold 
better substrate for PP-2A than PP-1), injecting equal activi- 
ties towards this substrate would have led us to underestimate 
the  amount  of PP-2A  required  for  injection  (although  it 
would not have changed the result). Fig. 2 shows the effects 
of microinjection of PP-2A (1.7 mg/ml, 15,000-17,000 U/ml) 
on actin filament organization. The cells injected with PP-2A 
(marked by control antibody staining in Fig. 2 B), show only 
very subtle changes in organization of actin when compared 
to the surrounding control cells (shown in Fig. 2 A). We did 
observe a small proportion of the cells showing a more pro- 
nounced effect on actin organization, but this never reached 
the extent observed after injection of PP-1. (Indeed, the sub- 
tle changes were similar to those observed when lower con- 
centrations [0.1 mg/ml] of PP-1 were microinjected.) Since 
there is evidence that type-1 activity may contaminate prepa- 
rations of PP-2A (,x,5 % [12]), we proceeded to reanalyze the 
effects of PP-2A in the presence of antibodies inhibitory to 
phosphatase type-1  activity and that have no effect towards 
type-2A activity in vitro (12).  When a  solution of PP-2A 
(17,000  U/ml)  containing 0.5  mg/ml  anti-PP-1  antibodies 
was microinjected into REF-52 cells, injected cells (Fig. 2 
D) showed no change in actin distribution (Fig. 2 C) when 
compared to surrounding cells. This absence of an effect of 
PP-2A injected in the presence of anti-PP-1  was observed 
over a wide range of  concentrations of PP-2A, indicating that 
the subtle effects on actin distribution seen when injecting 
PP-2A alone were most likely due to low levels of contam- 
inating PP-1 in the PP-2A preparation. This conclusion was 
also.confirmed by passing the preparation of PP-2A through 
heparin-Sepharose, which removes possible contaminating 
PP-1, a treatment that resulted in effectively abolishing the 
minor effects previously observed on actin filaments even at 
high concentrations of injected PP-2A (1.7 rng/ml). The amount 
of PP-2A injected here (1.7 mg/ml), represents approximately 
fivefold  more PP-2A activity than the minimal activity of PP-1 
found to have an effect on actin filament organization. We 
have also observed that injection of the native holoenzyme 
form of PP-2A has no effect on actin organization (data not 
shown). Moreover, over expression of PP-2A after microin- 
jection of a plasmid (pCMV, bearing a cytomegalovirus pro- 
moter) encoding the PP-2A catalytic subunlt, did not induce 
any changes  in  cell  actin organization  (although  showing 
some other effects on the ceils, like the highest concentration 
of PP-2A enzyme used here, these effects are currently under 
investigation) (data not shown). 
Dephosphorylation of Myosin Light Chain 
in Response to Microinjection of 7)~e-I Phosphatase, 
but Not ~e  2A Phosphatase, Coincides with 
Actin Reorganization 
Since dephosphorylation of myosin light chain correlated 
with  the  reorganization of actin  microfilaments  (33),  we 
therefore tested to see if the reorganization of actin induced 
by injection of PP-1 also was accompanied by dephosphory- 
lation  of myosin light  chain.  Cells  were plated  on  small 
glass coverslips and after injecting each cell on the coverslip 
(equal numbers for each experiment) with injection buffer, 
or PP-1 or PP-2A,  the coverslips were transferred to hu- 
midified chambers and incubated with [32p]orthophosphate 
for 30 min. After labeling, cells were solubilized and ana- 
lyzed for changes in phosphoproteins by two-dimensional 
PAGE. We had previously identified and localized MLC on 
our gel system (33). As shown in Fig. 3 A, confirming our 
previous findings, in control cells or cells injected with buf- 
fer alone, the myosin light chain appears as two phosphopro- 
tein spots, one more heavily phosphorylated and running as 
a more acidic isoform. Cells microinjected with PP-1 show 
a marked diminution in the labeling of MLC within 30 min, 
particularly on the more heavily phosphorylated acidic form 
(Fig. 3 B). In some experiments we observed the complete 
dephosphorylation of this acidic form of MLC leaving only 
the more basic phosphoisoform. The dephosphorylation of 
MLC  after injection of PP-1 was  most pronounced when 
Fernandez et al. Phosphatase Type-I and Actomyosin Regulation  107 Figure 4. Immunocytolocalization  of PP-I in REF-52 cells fixed after brief detergent extraction. REF-52 cells were grown  on coverslips 
and extracted for 30 s in 0.3 % Triton X-100 in 10 mM Hepes, pH 7.5, followed  by fixation in 3.7 % formalin and acetone extraction, before 
staining for the distribution of  actin and PP-1 as described in Materials and Methods. Shown  are fluorescence  micrographs of  the distribution 
of actin (A and C) and PP-I (B and D). Bars: (B) 10/~m; (D) 5 #m. 
cells were labeled from 15 to 45 rain after injection, which 
coincides temporally with the most extensive actin reorgani- 
zation. When PP-2A phosphatase was microinjected (Fig. 3 
C), there was little or no difference in MLC phosphorylation 
between control cells (Fig. 3 A) and cells injected with PP-2A 
(Fig. 3 C). To confirm that these proteins were indeed MLC 
we performed Western immunoblotting of cells after injec- 
tion of phosphatases. Fig. 3 D shows a typical Western blot 
using anti-MLC (a generous gift from Dr. James StuU, Uni- 
versity of  Texas, Dallas, Texas). Again, as we have described 
previously, in our gel system MLC resolves as two spots, the 
more heavily staining acidic spot resolving exactly over the 
position of the more heavily 32P-labeled isoform of MLC. 
Since we do not observe any other proteins reacting with 
these antibodies, we must conclude that the constitutively 
low level phosphorylated isoform resolves closely or to the 
same position as the unphosphorylated isoform. From this 
data it is clear that the phosphoisoform of MLC which shows 
the most prominent dephosphorylation after injection of PP-1, 
and not PP-2A, corresponds to the form that we have previ- 
ously shown to decrease its phosphorylation after injection 
of  A-kinase or antibodies that inactivate MLCK in vivo (33). 
Although no changes in MLC phosphorylation were observed 
after injection of PP-2A, we did observe a few other proteins 
on the two-dimensional PAGE,  which showed changes in 
phosphorylation. However, none of these proteins appeared 
to correspond to known actin binding proteins (for example, 
heavy myosin) and since most of these are as yet unidentified 
further research will be required to ascertain the potential 
implication of this effect that does not clearly relate to the 
present study on actomyosin. However,  these data indicate 
that the PP-2A preparation we are using is active inside the 
REF-52 cells. Taken together, these results provide additional 
evidence that the disassembly of actin microfilaments in fi- 
broblasts involves the dephosphorylation of MLC and indi- 
cate that this dephosphorylation of MLC appears to be cata- 
lyzed predominantly by type-1 phosphatase. The selectivity 
of  this effect  provides some of  the first evidence of  differential 
substrate specificity for phosphatases in living cells. 
75ype-1 Phosphatase Antisera Stain Predominantly 
Actin Microfilaments in Extracted Cells 
Providing further support for the potential role of type-I 
phosphatase in aedn filament organization, we have observed 
by immunofluorescence staining using an affinity-purified 
anti-PP-1  antibody, the decoration of the actin filament net- 
work. In cells fixed after a brief extraction with 0.3 % Triton 
X-100, staining for PP-1 revealed a fibrillar pattern (Fig. 4, 
B-D),  exactly overlaying the staining for actin microfila- 
ments (Figr4, A-C) produced by rhodamine phalloidin. We 
also observed some actin filament staining in cells that had 
The Journal of Cell Biology,  Volume 111, 1990  108 Figure 5.  Coinjection  of anti-PP-1  antibodies  with the  cAMP-dependent protein  kinase  (A-kinase) prevents the  disassembly  of actin 
microfilaments induced by injection of A-kinase alone. The purified catalytic subunit of cAMP-dependent protein kinase (0.5 mg/ml) with 
and without afffinity-purified antibodies directed against phosphatase type-1 (0.5 mg/ml) were microinjected  into rat embryo fibroblasts 
growing on glass coverslips. 45 min thereafter, coverslips were fixed and stained for the distribution of an inert antibody coinjected to 
identify microinjected cells and for the distribution of actin. Shown are fluorescence micrographs of the distribution of marker antibody 
(A and C) or actin (B and D). A and B show cells injected with the kinase alone, C and D show cells injected with the kinase and anti-PP-1 
simtdtaneously. Bar,  10 t~m. 
not been extracted (data not shown), implying that the actin 
staining pattern is not an artifact of the extraction procedure. 
Indeed the staining pattern could be abolished by preincubat- 
ing the antibody with purified PP-1, but not with PP-2A (data 
not shown). It is also possible to observe some nuclear local- 
ization of PP-1 (in Fig. 4 B) in agreement with other previous 
studies using proteins fractionated from isolated nuclei (24, 
31). Interestingly, although the pattern is faint, there does not 
appear to be any clear evidence of striated staining charac- 
teristic similar to the patterns seen for some of the other actin 
binding regulatory proteins (for example, ~actinin, myosin, 
and MLCK [21, 23]. 
Microfilament Disassembly Induced by A-Kinase Is 
Prevented by Coinjection of  Antibodies Specifw for 
Protein Phosphatase Dype-1 or Phosphatase Inhibitor-2 
Our  previous  studies  demonstrated  that  microinjection  of 
A-kinase induced disassembly of actin microfilaments through 
a mechanism involving MLCK inactivation,  and the result- 
ing dephosphorylation of MLC (33). The finding that micro- 
injection of PP-1  induces the disassembly of the actin mi- 
crofilaments in a manner similar to that observed after MLCK 
inactivation, suggests that type-1 phosphatase may play a role 
in the dephosphorylation of MLC that accompanied the reor- 
ganization  of the microfilaments  after A-kinase activation. 
To test this possibility, we examined the effect of coinjecting 
the catalytic subunit of A-kinase (0.5 mg/ml) plus affinity- 
purified anti-PP-1 antibodies (0.5 mg/ml), which specifically 
neutralize  type-1 phosphatase activity in vitro (12). 
As shown in Fig. 5, elevation of intracellular A-kinase lev- 
els through microinjection of the catalytic subunit of A-ki- 
nase together with inert antibodies rapidly induced the disas- 
sembly of microfilarnents such that injected cells (Fig. 5 A) 
showed little or no actin microfilament staining  (Fig.  5 B) 
60 min after injection. In marked contrast,  we observed no 
such effects in cells coinjected with A-kinase and antibodies 
that neutralize type-1 phosphatase, and by 60 min after injec- 
tion, injected cells (Fig.  5 C) still contain a distribution of 
microfilaments  indistinguishable  from that  in  surrounding 
uninjected cells (Fig.  5 D).  This effect was observed using 
a wide range of concentrations  of A-kinase from 0.1 to 3.0 
mg/ml.  Increasing the concentration  of anti-PP-1  antibody 
coinjected with A-kinase still prevented actin reorganization 
by A-kinase, whereas lowering the concentration of the anti- 
body below 0.1 mg/ml led to actin reorganization, just as ob- 
served in ceils injected with A-kinase alone. Confirming this 
effect of anti-PP-1, coinjection of purified phosphatase inhib- 
itor-2 (0.3 mg/ml) with A-kinase also prevented microfila- 
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shown). These results confirm that the effect of A-kinase on 
the actin mierofilaments  indeed depends upon the presence 
of active phosphatase typed, since neutralizing  this enzyme 
in living cells prevented  the disassembly of actin filaments 
normally observed after A-kinase microinjection.  In further 
support of this conclusion, we have performed the same ex- 
periment with cells treated with the phosphatase inhibitor 
okadaic acid (8, 30, 45). When cells were treated with low 
concentrations  of okadiac acid (10 nM), injection  of A-ki- 
nase induced effects on actin filaments  similar  to those we 
have described before or shown in Fig. 5 B. At this concen- 
tration  okadiac acid is an effective inhibitor of PP-2A only 
(8, 30). However, when the same experiment is performed 
in the presence of 1 #M okadiac acid (which  inhibits  both 
PP-1 and PP-2A), we observed no effects on actin organiza- 
tion after injection  of A-kinase (data not shown).  Taken to- 
gether with the results  of injecting  purified  phosphatases, 
these results imply an integral  role for protein phosphatase 
typed in microfilament  organization. 
Discussion 
Through microinjection  of the purified catalytic subunits of 
typed and type-2A phosphatases,  we examined the involve- 
ment of  these proteins in modulating the organization of  actin 
microfilaments  in living  nonmuscle cells. 
The increased tension of different muscle types is associ- 
ated with an overall increase in phosphorylation of the light 
chains of myosin (Mr 20-22 kD) (1, 2, 5, 17, 19, 20, 27, 41), 
which appears  to involve activation  of a calcium-calmodu- 
lin-dependent  protein  kinase  (MLCK)  (1-3, reviewed  in 
references 32, 43) although other kinases can phosphorylate 
MLC (44). Phosphorylation of MLCK by A-kinase results 
in a reduction in MLCK activity since it occurs at the cal- 
modulin binding  site (17, 19, 28, reviewed in reference 43). 
We have shown recently that inactivation of MLCK in living 
fibroblasts by microinjection  of cAMP-dependent protein ki- 
nase (A-kinase) or anti-MLCK antibodies resulted in micro- 
filament disassembly and MLC dephosphorylation (33). The 
present study,  using  microinjection of phosphatases,  pro- 
vides further confirmation  that in nonmuscle cells, dephos- 
phorylation of MLC, most likely at the MLCK site, results 
in actin filament disassembly.  As reviewed in references  27 
and 43,  the potential  mechanisms  to account for such  an 
effect may involve changes in myosin-MgATPase activity and 
the conversion of myosin monomers from 10S to 6S confor- 
mation, both events being regulated by MLC phosphorylation. 
Protein phosphatases reactive  with MLC have been iso- 
lated from smooth muscle (22, 26, 29, 37-39, 45, reviewed 
16, 40), as well as from cardiac (36, 37, 42) and skeletal mus- 
cle (14, 15, reviewed in reference 16) and appear to be related 
to either type-1 (14, 15, 42, reviewed in reference 16) or type 
2A enzymes (8,  10, 26,  30).  Both a polycation-modulated 
phosphatase holoenzyme (9) and the catalytic subunit of a 
skeletal protein phosphatase (41) have been found to decrease 
isometric tension  of skinned  smooth muscle and  skeletal 
muscle fibers respectively.  Both these protein phosphatase 
preparations  are likely to be classed as type-2A phospha- 
tases (16). It remains unclear whether the activity observed 
with skinned muscle fibers resulted from cross-contamina- 
tion of these preparations with type-1 phosphatase activity, 
as pointed out in the present study, or whether reactivity with 
type-2A phosphatase was due to changes in structure of ac- 
tomyosin during preparation of skinned fibers, rendering  it 
susceptible  to  dcphosphorylation  since,  indeed,  isolated 
MLC are subst~ates in vitro for PP-2A (35).  One possible 
source of error in identifying  the phosphatases responsible 
for dephosphorylating  myosin light chain arises from cate- 
gorizing the phosphatase as type-1 or type-2A. For example 
many of the in vitro properties of the phosphatases from 
smooth muscle are not entirely consistent with the functional 
criteria of type-1 since, although they preferentially  dephos- 
pborylate the/3-subunit of phosphorylase kinase  and bind 
heparin-agarose  (like typed phosphatase), they are insensi- 
tive to inhibitor 2 (40). As reviewed by Cohen (16), there is 
strong evidence that a type-1 phosphatase enzyme, PP-1M, 
and not a type-2A enzyme, is responsible for the dephos- 
phorylation  of intact  actomyosin,  despite the capacity of 
purified type-2A enzymes to dephosphorylate isolated myo- 
sin light chains and in some cases induce relaxation of intact 
sunned smooth muscle fibers. Alternatively, both classes of 
phosphatase may dephosphorylate sites on MLC, but these 
sites may be different.  For example,  as reported by Erdodi 
et al.  (22),  PP-l-related  phosphatase more effectively de- 
phosphorylates the MLCK sites on actomyosin whereas a 
type-2A-relate£1 phosphatase activity preferentially brought 
about the dephosphorylation of a threonine  at the putative 
protein kinase-C phosphorylation site (for example,  see ref- 
erence 43). Therefore,  the identity of the phosphatase(s)  re- 
sponsible for myosin  light  chain  dephosphorylation at the 
MLCK site (which is the site involved in the dephosphoryla- 
tion-dependent  relaxation  of actomyosin) in living cells has 
not been rigorously established.  Here, we have shown that 
in living nonmuscle cells, the endogenous MLC phosphatase 
can be blocked by anti-PP-1  antibodies,  thereby preventing 
microfilament  reorganization  induced by A-kinase. Interest- 
ingly, our observations  that PP-1 is implicit  in actomyosin 
regulation after A-kinase injection suggests that phosphatase 
inhibitor-1 (the A-kinase activated inhibitor  specific for PP-1 
[for example,  see reference 16]) does not play an active role 
in modulating PP-1M (the form of PP-1 bound to actomyosin; 
16) activity in REF-52 cells. Microinjection of purified skel- 
etal muscle typed phosphatase also produces morphological 
reorganization  of the  actin  microfilaments  in  rat  embryo 
fibroblasts  and decreased myosin light  chain  phosphoryla- 
tion,  whereas type-2A catalytic subunlt induced only mini- 
mal  effects on microfilament  organization  or MLC phos- 
phorylation and these could be blocked by coinjection of 
anti-PP-1  antibodies. 
Whereas our data strongly indicate that PP-2A does not in- 
duce dephosphorylation of MLC in rive, or changes in actin 
organization,  we do not consider that these reflect a general 
lack of activity of the PP-2A preparations  for several rea- 
sons. Firstly, the same results were obtained with a number 
of different preparations  of PP-2A, the activity of which was 
verified in vitro during the microinjection  experiments.  Fur- 
thermore,  whereas there appeared to be no changes in myo- 
sin phosphorylation, a few other proteins showed alterations 
in phosphorylation  after microinjection of PP-2A. Moreover, 
using plasmids  that overexpress active PP-2A catalytic sub- 
unit we have also observed no changes in actin organization 
(while such an injection does produce other effects in cells, 
as also observed with the highest  concentrations  of PP-2A 
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no effect on the reorganization of actin filaments by A-kinase 
(using low concentrations of okadaic acid), the inhibition of 
PP-1 (and PP-2A) by high concentrations of this compound 
does prevent A-kinase-induced  actin reorganization.  Alto- 
gether,  these results demonstrate a high degree  of in vivo 
substrate specificity for typed and type-2A protein phospha- 
tases towards intact intracellular actomyosin, and show that 
only type-1 protein phosphatase operates in vivo to dephos- 
phorylate  the  light  chains  of nonmuscle  (smooth  muscle 
type) myosin. 
This conclusion is consistent with the recent biochemical 
evidence  showing that type-1  phosphatase  associates  with 
myofibrils (14,  15, 42). Substantial amounts of PP-1 remain 
bound to either  skeletal  (14) or cardiac  muscle myofibrils 
(42) after extensive detergent extraction. These activity mea- 
surements are in agreement with our localization of PP-1 on 
microfilaments by immunofluorescence staining after Triton 
X-100 extraction. Interestingly, the staining pattern revealed 
by anti-PP-1  along the microfilament under these conditions 
(Fig. 4) seemed to be continuous. There was no evidence of 
the more common striated staining seen with many of the 
other actin binding or regulatory  proteins such as myosin 
light chain kinase, myosin light chain, or alpha-actinin (21, 
23). The absence of striated actin filament staining suggests 
that the phosphatase does not bind to (or localizes  to) one 
single actin binding protein. It may bind to two proteins which 
are adjacent to one another on the actin since this has been 
shown previously to produce complete staining pattern even 
if the staining pattern of either protein alone is striated (23). 
Our results implicating type-1 phosphatase as the predom- 
inant  myosin  phosphatase  in  nonmuscle  (smooth  muscle 
type) actomyosin are consistent with the effects of okadaic 
acid (8, 45) and calyculin (30), two toxins that induce con- 
traction of smooth muscle fibers. Whereas the okadaic acid 
result was obtained at concentrations where the toxin was in- 
hibitory to both typed  and type-2A protein phosphatases, 
calyculin  A  induced  muscle  contraction  at concentrations 
where it was 50-fold more inhibitory to type-1 phosphatase 
(30). 
The present data indicate that in mammalian cells type-1 
phosphatase plays an important role in regulating actomyo- 
sin activity. This role is consistent with our recent observa- 
tions that throughout the majority of the mammalian cell cy- 
cle,  the  type-1  phosphatase  is  localized  in  the  cytoplasm 
where the bulk of the actin is also found (Lamb,  N.  J. C., 
D. L. Brautigan, and A. Fernandez, manuscript in prepara- 
tion). While further work is still required to confirm that PP-1 
acts upon the same sites on myosin light chain that are phos- 
phorylated by MLCK in living cells and dephosphorylated 
during A-kinase induced actin disassembly, the present studies 
illustrate  for the first  time that type-1  phosphatase plays a 
major role in modulating the actin microfilament cytoskele- 
ton in living nonmuscle cells. 
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